-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Overweight on United Therapeutics, Lowers Price Target to $695

Benzinga·10/28/2026 19:52:51
Listen to the news
JP Morgan analyst Jessica Fye maintains United Therapeutics (NASDAQ:UTHR) with a Overweight and lowers the price target from $710 to $695.